advertisement
14 Costing studies; pharmacoeconomics (27)
Showing records 1 to 25
Display all abstracts in classification 14 Costing studies; pharmacoeconomics
Search within classification 14 Costing studies; pharmacoeconomics66610 Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D
Blumberg DM
JAMA ophthalmology 2016; 134: 212-220
66505 The Evolution of Teleophthalmology Programs in the United Kingdom: Beyond Diabetic Retinopathy Screening
Sim DA
Journal of diabetes science and technology 2016; 10: 308-317
65900 Variation in Number of Doses, Bottle Volume, and Calculated Yearly Cost of Generic and Branded Latanoprost for Glaucoma
Queen JH
American Journal of Ophthalmology 2016; 163: 70-74.e1
66596 Self-reported Function, Health Resource Use, and Total Health Care Costs Among Medicare Beneficiaries With Glaucoma
Prager AJ
JAMA ophthalmology 2016; 134: 357-365
66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Hernández R
British Journal of Ophthalmology 2016; 100: 1263-1268
65900 Variation in Number of Doses, Bottle Volume, and Calculated Yearly Cost of Generic and Branded Latanoprost for Glaucoma
Feldman RM
American Journal of Ophthalmology 2016; 163: 70-74.e1
66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Burr JM
British Journal of Ophthalmology 2016; 100: 1263-1268
66596 Self-reported Function, Health Resource Use, and Total Health Care Costs Among Medicare Beneficiaries With Glaucoma
Liebmann JM
JAMA ophthalmology 2016; 134: 357-365
66610 Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D
Prager AJ
JAMA ophthalmology 2016; 134: 212-220
66505 The Evolution of Teleophthalmology Programs in the United Kingdom: Beyond Diabetic Retinopathy Screening
Mitry D
Journal of diabetes science and technology 2016; 10: 308-317
66596 Self-reported Function, Health Resource Use, and Total Health Care Costs Among Medicare Beneficiaries With Glaucoma
Cioffi GA
JAMA ophthalmology 2016; 134: 357-365
66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Vale L
British Journal of Ophthalmology 2016; 100: 1263-1268
66610 Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D
Liebmann JM
JAMA ophthalmology 2016; 134: 212-220
66505 The Evolution of Teleophthalmology Programs in the United Kingdom: Beyond Diabetic Retinopathy Screening
Alexander P
Journal of diabetes science and technology 2016; 10: 308-317
65900 Variation in Number of Doses, Bottle Volume, and Calculated Yearly Cost of Generic and Branded Latanoprost for Glaucoma
Lee DA
American Journal of Ophthalmology 2016; 163: 70-74.e1
66505 The Evolution of Teleophthalmology Programs in the United Kingdom: Beyond Diabetic Retinopathy Screening
Mapani A
Journal of diabetes science and technology 2016; 10: 308-317
66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Azuara-Blanco A
British Journal of Ophthalmology 2016; 100: 1263-1268
66596 Self-reported Function, Health Resource Use, and Total Health Care Costs Among Medicare Beneficiaries With Glaucoma
Blumberg DM
JAMA ophthalmology 2016; 134: 357-365
66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Cook JA
British Journal of Ophthalmology 2016; 100: 1263-1268
66505 The Evolution of Teleophthalmology Programs in the United Kingdom: Beyond Diabetic Retinopathy Screening
Goverdhan S
Journal of diabetes science and technology 2016; 10: 308-317
66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Banister K
British Journal of Ophthalmology 2016; 100: 1263-1268
66505 The Evolution of Teleophthalmology Programs in the United Kingdom: Beyond Diabetic Retinopathy Screening
Aslam T; Tufail A
Journal of diabetes science and technology 2016; 10: 308-317
66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Tuulonen A
British Journal of Ophthalmology 2016; 100: 1263-1268
66505 The Evolution of Teleophthalmology Programs in the United Kingdom: Beyond Diabetic Retinopathy Screening
Egan CA
Journal of diabetes science and technology 2016; 10: 308-317
66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Ryan M
British Journal of Ophthalmology 2016; 100: 1263-1268
